Giulio Mengozzi

5.6k total citations · 1 hit paper
174 papers, 3.9k citations indexed

About

Giulio Mengozzi is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Giulio Mengozzi has authored 174 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Endocrinology, Diabetes and Metabolism, 44 papers in Surgery and 29 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Giulio Mengozzi's work include Hormonal Regulation and Hypertension (37 papers), Adrenal and Paraganglionic Tumors (21 papers) and Adrenal Hormones and Disorders (17 papers). Giulio Mengozzi is often cited by papers focused on Hormonal Regulation and Hypertension (37 papers), Adrenal and Paraganglionic Tumors (21 papers) and Adrenal Hormones and Disorders (17 papers). Giulio Mengozzi collaborates with scholars based in Italy, Belarus and United States. Giulio Mengozzi's co-authors include Paolo Mulatero, Franco Veglio, Chiara Bertello, Franco Rabbia, Silvia Monticone, Tracy Ann Williams, Davide Tizzani, Fabrizio Buffolo, Jacopo Burrello and Andrea Viola and has published in prestigious journals such as Nature Communications, Journal of the American College of Cardiology and PLoS ONE.

In The Last Decade

Giulio Mengozzi

164 papers receiving 3.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prevalence and Clinical Manifestations of Primary Aldosteronism Encountered in Primary Care Practice

2017 539 citations Silvia Monticone, Giulio Mengozzi et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Giulio Mengozzi Italy	32	1.7k	1.7k	646	460	404	174	3.9k
Trond Jenssen Norway	37	1.7k 1.0×	1.4k 0.9×	591 0.9×	435 0.9×	904 2.2×	123	4.9k
Vincent Rigalleau France	35	1.3k 0.8×	540 0.3×	501 0.8×	425 0.9×	352 0.9×	164	3.6k
Violeta Raverdy France	23	1.0k 0.6×	1.2k 0.7×	1.5k 2.4×	320 0.7×	500 1.2×	41	3.8k
Juan Carlos Ruiz Spain	37	560 0.3×	1.8k 1.0×	714 1.1×	613 1.3×	614 1.5×	262	6.1k
Bernhard M. W. Schmidt Germany	36	1.0k 0.6×	989 0.6×	513 0.8×	1.3k 2.8×	728 1.8×	114	4.5k
Kyu Yeon Hur South Korea	38	1.7k 1.0×	1.0k 0.6×	1.3k 2.1×	443 1.0×	1.2k 3.0×	185	4.6k
Chang Hee Jung South Korea	34	1.6k 0.9×	772 0.5×	1.2k 1.9×	909 2.0×	824 2.0×	174	4.3k
Haralampos J. Milionis Greece	30	742 0.4×	903 0.5×	422 0.7×	376 0.8×	367 0.9×	59	3.2k
Apostolos Hatzitolios Greece	31	562 0.3×	819 0.5×	846 1.3×	699 1.5×	371 0.9×	171	3.3k
Alper Sönmez Türkiye	41	1.1k 0.7×	918 0.5×	1.2k 1.9×	1.2k 2.7×	734 1.8×	169	4.9k

Countries citing papers authored by Giulio Mengozzi

Since Specialization

Citations

This map shows the geographic impact of Giulio Mengozzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giulio Mengozzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giulio Mengozzi more than expected).

Fields of papers citing papers by Giulio Mengozzi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giulio Mengozzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giulio Mengozzi. The network helps show where Giulio Mengozzi may publish in the future.

Co-authorship network of co-authors of Giulio Mengozzi

This figure shows the co-authorship network connecting the top 25 collaborators of Giulio Mengozzi. A scholar is included among the top collaborators of Giulio Mengozzi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giulio Mengozzi. Giulio Mengozzi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Andreis, Alessandro, Guglielmo Beccuti, Arianna Ferro, et al.. (2025). Neck Circumference and the Heart: Unveiling a New Anthropometric Marker for LVH Risk in Type 2 Diabetes—The TESEO Study. Diabetes/Metabolism Research and Reviews. 41(8). e70106–e70106.

Leoni, Laura, Mirko Parasiliti‐Caprino, Fabio Settanni, et al.. (2025). Determination of human urinary cortisol, cortisone and relative phase II metabolites by dilute-and-shoot LC-MS/MS analysis: an application to adrenal disease. Clinica Chimica Acta. 574. 120324–120324.

Ponzetto, Federico, et al.. (2024). Investigation of circulating androgens’ circadian variations: Expanding the knowledge by monitoring phase ii metabolites. Clinica Chimica Acta. 558. 118235–118235. 1 indexed citations

Prencipe, Nunzia, Fabio Bioletto, Fabio Settanni, et al.. (2024). Effectiveness of Copeptin, MR-proADM and MR-proANP in Predicting Adverse Outcomes, Alone and in Combination with Traditional Severity Scores, a Secondary Analysis in COVID-19 Patients Requiring Intensive Care Admission. Journal of Clinical Medicine. 13(7). 2019–2019. 1 indexed citations

Parasiliti‐Caprino, Mirko, Federico Ponzetto, Iacopo Gesmundo, et al.. (2024). Asymmetric and symmetric dimethylarginine as markers of endothelial dysfunction in cerebrovascular disease: A prospective study. Nutrition Metabolism and Cardiovascular Diseases. 34(7). 1639–1648. 2 indexed citations

Campion, Daniela, Paola Ponzo, À. Risso, et al.. (2023). A prospective, multicenter, three-cohort study evaluating contrast-induced acute kidney injury (CI-AKI) in patients with cirrhosis. Journal of Hepatology. 80(1). 62–72. 4 indexed citations

Montrucchio, Giorgia, et al.. (2022). Proadrenomedullin in the Management of COVID-19 Critically Ill Patients in Intensive Care Unit: A Systematic Review and Meta-Analysis of Evidence and Uncertainties in Existing Literature. Journal of Clinical Medicine. 11(15). 4543–4543. 10 indexed citations

Vicentini, Costanza, Savina Ditommaso, Monica Giacomuzzi, et al.. (2022). Seroprevalence of infection-induced SARS-CoV-2 antibodies among health care users of Northern Italy: results from two serosurveys (October-November 2019 and September-October 2021). International Journal of Infectious Diseases. 124. 49–54. 1 indexed citations

Porreca, Annamaria, et al.. (2022). Impact of COVID-19 Infection, Vaccination, and Serological Response in Immune Thrombocytopenic Purpura Patients: A Single-Center Global Analysis. Biomedicines. 10(11). 2674–2674.

10.

Oderda, Marco, Giulio Mengozzi, Iacopo Gesmundo, et al.. (2022). Urinary Zinc Loss Identifies Prostate Cancer Patients. Cancers. 14(21). 5316–5316. 9 indexed citations

11.

Ruiu, Roberto, Giuseppina Barutello, Maddalena Arigoni, et al.. (2021). Identification of TENM4 as a Novel Cancer Stem Cell-Associated Molecule and Potential Target in Triple Negative Breast Cancer. Cancers. 13(4). 894–894. 8 indexed citations

12.

Occhipinti, Sergio, Giulio Mengozzi, Marco Oderda, et al.. (2021). Low Levels of Urinary PSA Better Identify Prostate Cancer Patients. Cancers. 13(14). 3570–3570. 14 indexed citations

13.

Montrucchio, Giorgia, Gabriele Sales, Vito Fanelli, et al.. (2021). Effectiveness of mid-regional pro-adrenomedullin (MR-proADM) as prognostic marker in COVID-19 critically ill patients: An observational prospective study. PLoS ONE. 16(2). e0246771–e0246771. 44 indexed citations

14.

Settanni, Fabio, et al.. (2021). Total Value of Ownership and Overall Equipment Effectiveness analysis to evaluate the impact of automation on time and costs of therapeutic drug monitoring. Analytica Chimica Acta. 1160. 338455–338455. 4 indexed citations

15.

Romano, Federica, Marta Giraudi, Giulio Mengozzi, et al.. (2021). Bidirectional Association between Metabolic Control in Type-2 Diabetes Mellitus and Periodontitis Inflammatory Burden: A Cross-Sectional Study in an Italian Population. Journal of Clinical Medicine. 10(8). 1787–1787. 31 indexed citations

16.

Managò, Antonella, Valentina Audrito, Francesca Mazzola, et al.. (2019). Extracellular nicotinate phosphoribosyltransferase binds Toll like receptor 4 and mediates inflammation. Nature Communications. 10(1). 4116–4116. 55 indexed citations

17.

Piovano, Elisa, Luca Fuso, E. Viora, et al.. (2016). Diagnostic accuracy and cost‐effectiveness of different strategies to triage women with adnexal masses: a prospective study. Ultrasound in Obstetrics and Gynecology. 50(3). 395–403. 28 indexed citations

18.

Mengozzi, Giulio, et al.. (2013). Plasma brain derived neurotrophic factor levels and neuropsychological aspects of depressed patients treated with paroxetine.. PubMed. 55(4). 377–84. 15 indexed citations

19.

Montaruli, Barbara, Giulio Mengozzi, Filippo Molinari, et al.. (2012). Anti-cardiolipin and anti-β2-glycoprotein I antibodies: normal reference ranges in northwestern Italy. Lupus. 21(7). 799–801. 11 indexed citations

20.

Williams, Tracy Ann, Silvia Monticone, Fulvio Morello, et al.. (2010). Teratocarcinoma-Derived Growth Factor-1 Is Upregulated in Aldosterone-Producing Adenomas and Increases Aldosterone Secretion and Inhibits Apoptosis In Vitro. Hypertension. 55(6). 1468–1475. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact